Approval · Notice of Compliance 26466 · 2021
BICALUTAMIDE: Notice of Compliance 26466
Issued August 18, 2021
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 26466
- Date
- August 18, 2021
- Company
- Sanis Health Inc.Brampton, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- Administrative: Licensing Agreement Between Two Companies
- Canadian reference product
- CASODEX (Astrazeneca Canada Inc)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| BICALUTAMIDE | 02519178 | Marketed |
Medicinal ingredients
- BICALUTAMIDE 50 MG per TAB